Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Go back to Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management
(NASDAQ: GPCR) Delayed: 22.51 -0.37 (1.62%)
Previous Close $22.88    52 Week High $ 
Open $23.00    52 Week Low $ 
Day High $23.32    P/E N/A 
Day Low $22.03    EPS $ 
Volume 234,540